bioAffinity Technologies (NASDAQ:BIAFW) Trading Up 20.6% – Here’s What Happened
by Michael Walen · The Markets DailyShares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) traded up 20.6% during mid-day trading on Thursday . The stock traded as high as $0.34 and last traded at $0.34. 1 shares traded hands during trading, a decline of 100% from the average session volume of 1,833 shares. The stock had previously closed at $0.2819.
bioAffinity Technologies Price Performance
The stock’s 50 day moving average is $0.30 and its two-hundred day moving average is $0.25.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.